The challenge of crowded digital channels, GSK’s Peter Howarth, why vaccinations are important, and the power of behaviour change
Celebrating the virtual Communique Awards 2020 and understanding the importance of behaviour change
Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but a foe.
Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but a foe.
Our cover star this month is a plucky little bronze statue called Fearless Girl. She originally took up her defiant pose outside the New York Stock Exchange, but can currently be found in London outside London’s own stock exchange.
We are currently just at the beginning of the cell and gene therapy revolution, one which promises to cure previously untreatable diseases – and all with a single treatment.
The long-running row between Vertex and NHS England and NICE over Orkambi has been a low point in the world of UK market access
The EMA’s departure is a tragedy for the UK – but we’re heading for a bigger one
The very idea of being able to edit our genes still sounds like something from science fiction, but in 2019, it is now very much a scientific reality.
Just a few years into the New Year, the $74bn acquisition of Celgene by BMS has woken us all up from our post-festive slump with a bang. The merger is the fourth biggest ever, and could spark more multi-billion dollar M&A deals over the next 12 months.
Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...